Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Inventory (2016 - 2026)

Phibro Animal Health has reported Inventory over the past 13 years, most recently at $517.3 million for Q4 2025.

  • For Q4 2025, Inventory rose 21.1% year-over-year to $517.3 million; the TTM value through Dec 2025 reached $517.3 million, up 21.1%, while the annual FY2025 figure was $444.4 million, 67.13% up from the prior year.
  • Inventory for Q4 2025 was $517.3 million at Phibro Animal Health, up from $471.8 million in the prior quarter.
  • Over five years, Inventory peaked at $517.3 million in Q4 2025 and troughed at $206.3 million in Q1 2021.
  • A 5-year average of $311.0 million and a median of $280.0 million in 2022 define the central range for Inventory.
  • Biggest five-year swings in Inventory: dropped 4.2% in 2024 and later skyrocketed 73.09% in 2025.
  • Year by year, Inventory stood at $230.8 million in 2021, then increased by 25.22% to $289.0 million in 2022, then fell by 0.8% to $286.7 million in 2023, then soared by 49.02% to $427.2 million in 2024, then increased by 21.1% to $517.3 million in 2025.
  • Business Quant data shows Inventory for PAHC at $517.3 million in Q4 2025, $471.8 million in Q3 2025, and $444.4 million in Q2 2025.